Borjeson-Forssman-Lehmann Syndrome: Clinical Features and Diagnostic Challenges

Overview

Journal Brain Neurorehabil

Date 2023 Dec 4

PMID 38047102

Authors

Marya Hameed

Fatima Siddiqui

Fahad Hassan Sheikh

Muhammad Khuzzaim Khan

Bushra Admani

Prasanna Kumar Gangishetti

Affiliations

Soon will be listed here.

Abstract

Borjeson-Forssman-Lehmann syndrome (BFLS) is an X-linked recessive disorder resulting from mutations in the gene. The syndrome is characterized by short stature, obesity, hypogonadism, hypotonia, intellectual disability, distinctive facial features, fleshy ears, and finger and toe abnormalities. However, the diagnostic challenge in identifying BFLS remains a topic of interest. In this case report, we present the clinical characteristics of a proband with BFLS, highlighting the additional features of hypotonia, intellectual disability, and distinctive facial features. While no definitive treatment exists for BFLS, patients benefit from specialized education and ongoing supervision from early childhood through adulthood. Symptomatic treatment, including close follow-up, may be necessary for complications such as seizures and hearing problems. Mastectomy or testosterone replacement therapy may be considered on a case-by-case basis. Genetic counseling for X-linkage should be offered to affected families.

References

Alvarez S, da Silva Almeida A, Albero R, Biswas M, Barreto-Galvez A, Gunning T . Functional mapping of PHF6 complexes in chromatin remodeling, replication dynamics, and DNA repair. Blood. 2022; 139(23):3418-3429. PMC: 9185155. DOI: 10.1182/blood.2021014103. View

Zweier C, Kraus C, Brueton L, Cole T, Degenhardt F, Engels H . A new face of Borjeson-Forssman-Lehmann syndrome? De novo mutations in PHF6 in seven females with a distinct phenotype. J Med Genet. 2013; 50(12):838-47. DOI: 10.1136/jmedgenet-2013-101918. View

Zhang C, Mejia L, Huang J, Valnegri P, Bennett E, Anckar J . The X-linked intellectual disability protein PHF6 associates with the PAF1 complex and regulates neuronal migration in the mammalian brain. Neuron. 2013; 78(6):986-93. PMC: 3694281. DOI: 10.1016/j.neuron.2013.04.021. View

Morgan-Smith M, Wu Y, Zhu X, Pringle J, Snider W . GSK-3 signaling in developing cortical neurons is essential for radial migration and dendritic orientation. Elife. 2014; 3:e02663. PMC: 4109311. DOI: 10.7554/eLife.02663. View

Turner G, GEDEON A, Mulley J, Sutherland G, RAE J, Power K . Börjeson-Forssman-Lehmann syndrome: clinical manifestations and gene localization to Xq26-27. Am J Med Genet. 1989; 34(4):463-9. DOI: 10.1002/ajmg.1320340402. View

Bardelli V, Arniani S, Pierini V, Di Giacomo D, Pierini T, Gorello P . T-Cell Acute Lymphoblastic Leukemia: Biomarkers and Their Clinical Usefulness. Genes (Basel). 2021; 12(8). PMC: 8394887. DOI: 10.3390/genes12081118. View

Lower K, Solders G, Bondeson M, Nelson J, Brun A, Crawford J . 1024C> T (R342X) is a recurrent PHF6 mutation also found in the original Börjeson-Forssman-Lehmann syndrome family. Eur J Hum Genet. 2004; 12(10):787-9. DOI: 10.1038/sj.ejhg.5201228. View

BORJESON M, FORSSMAN H, Lehmann O . An X-linked, recessively inherited syndrome characterized by grave mental deficiency, epilepsy, and endocrine disorder. Acta Med Scand. 1962; 171:13-21. DOI: 10.1111/j.0954-6820.1962.tb04162.x. View

Chao M, Todd M, Kontny U, Neas K, Sullivan M, Hunter A . T-cell acute lymphoblastic leukemia in association with Börjeson-Forssman-Lehmann syndrome due to a mutation in PHF6. Pediatr Blood Cancer. 2010; 55(4):722-4. PMC: 2933084. DOI: 10.1002/pbc.22574. View

10.

Robinson L, Culler F, Nyhan W, Sakati N, Jones K . The Börjeson-Forssman-Lehmann syndrome. Am J Med Genet. 1983; 15(3):457-68. DOI: 10.1002/ajmg.1320150311. View

11.

Eisa Y, Guo Y, Yang F . The Role of PHF6 in Hematopoiesis and Hematologic Malignancies. Stem Cell Rev Rep. 2022; 19(1):67-75. DOI: 10.1007/s12015-022-10447-4. View

12.

Yuan S, Wang X, Hou S, Guo T, Lan Y, Yang S . PHF6 and JAK3 mutations cooperate to drive T-cell acute lymphoblastic leukemia progression. Leukemia. 2021; 36(2):370-382. PMC: 8807395. DOI: 10.1038/s41375-021-01392-1. View

13.

Visootsak J, Rosner B, Dykens E, Schwartz C, Hahn K, White S . Clinical and behavioral features of patients with Borjeson-Forssman-Lehmann syndrome with mutations in PHF6. J Pediatr. 2004; 145(6):819-25. DOI: 10.1016/j.jpeds.2004.07.041. View

14.

Que Y, Li P, Hu S . [A case of Börjeson-Forssman-Lehmann syndrome caused by PHF6 gene mutation]. Zhonghua Er Ke Za Zhi. 2021; 59(5):414-416. DOI: 10.3760/cma.j.cn112140-20201015-00944. View

15.

Fliedner A, Gregor A, Ferrazzi F, Ekici A, Sticht H, Zweier C . Loss of PHF6 leads to aberrant development of human neuron-like cells. Sci Rep. 2020; 10(1):19030. PMC: 7642390. DOI: 10.1038/s41598-020-75999-2. View

16.

Gecz J, Turner G, Nelson J, Partington M . The Börjeson-Forssman-Lehman syndrome (BFLS, MIM #301900). Eur J Hum Genet. 2006; 14(12):1233-7. DOI: 10.1038/sj.ejhg.5201639. View

17.

Ardinger H, Hanson J, ZELLWEGER H . Börjeson-Forssman-Lehmann syndrome: further delineation in five cases. Am J Med Genet. 1984; 19(4):653-64. DOI: 10.1002/ajmg.1320190405. View

18.

Crawford J, Lower K, Hennekam R, Van Esch H, Megarbane A, Lynch S . Mutation screening in Borjeson-Forssman-Lehmann syndrome: identification of a novel de novo PHF6 mutation in a female patient. J Med Genet. 2005; 43(3):238-43. PMC: 2563250. DOI: 10.1136/jmg.2005.033084. View

19.

Zweier C, Rittinger O, Bader I, Berland S, Cole T, Degenhardt F . Females with de novo aberrations in PHF6: clinical overlap of Borjeson-Forssman-Lehmann with Coffin-Siris syndrome. Am J Med Genet C Semin Med Genet. 2014; 166C(3):290-301. DOI: 10.1002/ajmg.c.31408. View